Similar articles for PMID: 25002172

Year	Number of Results
1997	1
1998	2
1999	4
2000	9
2001	2
2002	5
2003	7
2004	6
2005	7
2006	12
2007	12
2008	17
2009	15
2010	10
2011	12
2012	20
2013	21
2014	17
2015	18
2016	17
2017	10
2018	5
2019	4
2020	9
2021	12
2022	2
2024	0

1

[Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study].

Gavazzi A, De Maria R, Grosu A, Iacovoni A, Fontana A, Gori M, Ferrari P, Canova P, Calabrese A, Filippi A, Rutili MR, Donzelli L, Parolini M, Senni M. Gavazzi A, et al. G Ital Cardiol (Rome). 2014 May;15(5):313-22. doi: 10.1714/1563.17033. G Ital Cardiol (Rome). 2014. PMID: 25002172 Italian.

2

[Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].

Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G. Tarantini L, et al. G Ital Cardiol (Rome). 2008 Dec;9(12):835-43. G Ital Cardiol (Rome). 2008. PMID: 19119693 Italian.

3

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H. McGrady M, et al. Int J Cardiol. 2013 Oct 30;169(2):133-8. doi: 10.1016/j.ijcard.2013.08.089. Epub 2013 Sep 7. Int J Cardiol. 2013. PMID: 24080362

4

Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.

Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Koç M, et al. Cardiol J. 2009;16(1):43-9. Cardiol J. 2009. PMID: 19130415 Free article.

5

Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.

Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M. Romano S, et al. J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):238-44. doi: 10.2459/JCM.0b013e3283212ee0. J Cardiovasc Med (Hagerstown). 2009. PMID: 19262210

6

Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.

Scrutinio D, Ammirati E, Guida P, Passantino A, Raimondo R, Guida V, Sarzi Braga S, Pedretti RF, Lagioia R, Frigerio M, Catanzaro R, Oliva F. Scrutinio D, et al. Int J Cardiol. 2013 Oct 3;168(3):2120-6. doi: 10.1016/j.ijcard.2013.01.005. Epub 2013 Feb 6. Int J Cardiol. 2013. PMID: 23395457

7

N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Krum H. McGrady M, et al. Eur J Heart Fail. 2013 May;15(5):573-80. doi: 10.1093/eurjhf/hft001. Epub 2013 Jan 20. Eur J Heart Fail. 2013. PMID: 23338855 Free article.

8

Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.

Mureddu GF, Tarantini L, Agabiti N, Faggiano P, Masson S, Latini R, Cesaroni G, Miceli M, Forastiere F, Scardovi AB, Uguccioni M, Boccanelli A. Mureddu GF, et al. Eur J Heart Fail. 2013 Oct;15(10):1102-12. doi: 10.1093/eurjhf/hft098. Epub 2013 Jun 20. Eur J Heart Fail. 2013. PMID: 23787717 Free article.

9

Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.

de Lemos JA, McGuire DK, Khera A, Das SR, Murphy SA, Omland T, Drazner MH. de Lemos JA, et al. Am Heart J. 2009 Apr;157(4):746-53.e2. doi: 10.1016/j.ahj.2008.12.017. Epub 2009 Feb 20. Am Heart J. 2009. PMID: 19332205

10

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Grewal J, et al. Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9. Am J Cardiol. 2008. PMID: 18773998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

222 results

Results by year